These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24113457)

  • 1. TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
    Alzoubi A; Almalouf P; Toba M; O'Neill K; Qian X; Francis M; Taylor MS; Alexeyev M; McMurtry IF; Oka M; Stevens T
    Am J Pathol; 2013 Dec; 183(6):1779-1788. PubMed ID: 24113457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial hyperpermeability in severe pulmonary arterial hypertension: role of store-operated calcium entry.
    Zhou C; Townsley MI; Alexeyev M; Voelkel NF; Stevens T
    Am J Physiol Lung Cell Mol Physiol; 2016 Sep; 311(3):L560-9. PubMed ID: 27422996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient Receptor Potential Channel 4 Encodes a Vascular Permeability Defect and High-Frequency Ca(2+) Transients in Severe Pulmonary Arterial Hypertension.
    Francis M; Xu N; Zhou C; Stevens T
    Am J Pathol; 2016 Jun; 186(6):1701-9. PubMed ID: 27083517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
    Christou H; Hudalla H; Michael Z; Filatava EJ; Li J; Zhu M; Possomato-Vieira JS; Dias-Junior C; Kourembanas S; Khalil RA
    J Pharmacol Exp Ther; 2018 Feb; 364(2):258-274. PubMed ID: 29212831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension.
    Jiang B; Deng Y; Suen C; Taha M; Chaudhary KR; Courtman DW; Stewart DJ
    Am J Respir Cell Mol Biol; 2016 Apr; 54(4):461-8. PubMed ID: 26291195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.
    Toba M; Alzoubi A; O'Neill KD; Gairhe S; Matsumoto Y; Oshima K; Abe K; Oka M; McMurtry IF
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(2):H243-50. PubMed ID: 24240870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced store-operated Ca²+ entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats.
    Liu XR; Zhang MF; Yang N; Liu Q; Wang RX; Cao YN; Yang XR; Sham JS; Lin MJ
    Am J Physiol Cell Physiol; 2012 Jan; 302(1):C77-87. PubMed ID: 21940663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension.
    Abe K; Shinoda M; Tanaka M; Kuwabara Y; Yoshida K; Hirooka Y; McMurtry IF; Oka M; Sunagawa K
    Cardiovasc Res; 2016 Jul; 111(1):16-25. PubMed ID: 27037259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension.
    Corboz MR; Plaunt AJ; Malinin V; Li Z; Gauani H; Chun D; Cipolla D; Perkins WR; Chapman RW
    Eur J Pharmacol; 2022 Feb; 916():174484. PubMed ID: 34508752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Tracking Suggests Pathophysiological and Therapeutic Role of Bone Marrow Cells in Sugen5416/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
    Miwa H; Sakao S; Sanada TJ; Suzuki H; Hata A; Shiina Y; Kobayashi T; Kato F; Nishimura R; Tanabe N; Voelkel N; Yoshino I; Tatsumi K
    Can J Cardiol; 2021 Jun; 37(6):913-923. PubMed ID: 33609715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.
    Shults NV; Kanovka SS; Ten Eyck JE; Rybka V; Suzuki YJ
    J Am Heart Assoc; 2019 Mar; 8(5):e011227. PubMed ID: 30807241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.
    Mizuno S; Farkas L; Al Husseini A; Farkas D; Gomez-Arroyo J; Kraskauskas D; Nicolls MR; Cool CD; Bogaard HJ; Voelkel NF
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):679-87. PubMed ID: 22842496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
    Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
    PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.
    Chaudhary KR; Deng Y; Suen CM; Taha M; Petersen TH; Mei SHJ; Stewart DJ
    Br J Pharmacol; 2018 Oct; 175(20):3976-3989. PubMed ID: 30098019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats.
    Silva MMCD; Alencar AKN; Silva JSD; Montagnoli TL; Silva GFD; Rocha BS; Montes GC; Mendez-Otero R; Pimentel-Coelho PM; Vasques JF; Trahez MM; Sudo RT; Zapata-Sudo G
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species induced Ca
    Suresh K; Servinsky L; Jiang H; Bigham Z; Yun X; Kliment C; Huetsch J; Damarla M; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L893-L907. PubMed ID: 29388466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detrimental Impact of Vasopressin V2 Receptor Antagonism in a SU5416/Hypoxia/Normoxia-Exposed Rat Model of Pulmonary Arterial Hypertension.
    Goto I; Dohi K; Ogihara Y; Okamoto R; Yamada N; Mitani Y; Ito M
    Circ J; 2016; 80(4):989-97. PubMed ID: 26924211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.
    Ivy DD; McMurtry IF; Colvin K; Imamura M; Oka M; Lee DS; Gebb S; Jones PL
    Circulation; 2005 Jun; 111(22):2988-96. PubMed ID: 15927975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.